Complex Coronary Interventions And Angioplasty Using Advanced Techniques
Peripheral Arterial (Renal, Extremities, Carotids) Angiography And Interventions
Stem cells and newer Research therapies in coronary and peripheral vasculature

Diagnosis and Treatment of Adult Cardiac and Vascular Diseases.

MBBS from Osmania Medical College, Andhra Pradesh University in 1994
Diplomate- Internal medicine from Chicago Medical School/Rosalind Franklin University in 1999
Diplomate- Cardiovascular diseases from Lutheran General Hospital,Chicago, IL 60068 in 2003
Diplomate- Interventional Cardiology from Harvard Medical School, Boston, MA in 2004

1. Heartland Regional Medical Center, Marion, IL, Community Health Systems, 12/2007 – 06/2010. Director, Cardiac Catheterization Lab, Community Health Systems [CHS], Heartland Regional Medical Center, IL.
2. Holmes Regional Medical Center, Melbourne, FL, Palm Bay Community Hospital, Palm Bay, FL, 11/2003- 06/2007.
3. Mt. Sinai Hospital, Chicago, USA, 08/1996- 07/1999.
4. VA Hospital, North Chicago, IL, Resurrection Hospital, Chicago, IL.
5. Senior Research Assistant, Dept. of Cardiology, Albert Einstein College of Medicine, New York , 12/1995- 08/1996.
6. Senior Resident, ICU / Cardiology, Apollo Hospitals, Hyderabad, India. 04/1994 – 12/1995.

1. Fellow American College of Cardiology [FACC]
2. Fellow Society of Coronary Angiography and Interventions [FSCAI]
3. Fellow American College of Physicians [FACP]
4. Counsel Member American Stroke Council
5.American board certified in Endovascular diseases and intervention : [FSVM]

1. Ashwani Malhotra, Vinay B. Sanghi: “Regulation of Contractile Proteins in Diabetic Heart” (Review). Cardiovascular Research 34 (1997) 34-40.
2. Ashwani Malhotra, David Reich, Daniel Reich, Antonio Nakouzi, Vinay B. Sanghi, David Geenen, Peter Buttrick: “Experimental Diabetes associated with Functional activation of Protein KinaseC? as Phosphorylation of Troponin I in the heart is prevented by AngII receptor blockade.” Circulation Research Vol. 81, No 6 December 1997 1027-1033.
3.Timothy Alikakos, Vinay Sanghi, Patricia Ingkanisorn, Steve Sundberg, Nagui Sabri. “Effect of Pretreatment with Eptifibatide in the Emergency Department on outcome of PCI in ST elevation MI.” Chicago cardiology group: Chicago, April 2002.
Abstract submitted to Journal of Am Coll Cardiology for review.

4. “Coronary saddle embolism in a 40 year old female with Mitral Prosthesis”: Shakil Aslam, Vinay Sanghi, Steve Hersh, Jeffrey Lakier. Catherization and Cardiovascular Interventions. 2002 Nov;57(3):367-70
5. “Retrospective, Angiographic study of extent of coronary atherosclerosis in Southeast Asian population compared to that of Caucasians.” Vinay Sanghi, Parag Patel, S. Amando, Jeffrey Lakier. Abstract submitted to Am Heart Journal for review.
6. Sanghi .V: Sub Investigator – Gibson CM, Kirtane AJ, Murphy SA, et al. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation Myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. Am Heart J. 2006 Oct;152(4):668-75
7. Sanghi.V: Sub Investigator – OASIS 6: Effects of Fondaparinux on Mortality and Reinfarction in Patients with Acute ST-Segment Elevation Myocardial Infarction. The OASIS-6 Randomized Trial. JAMA. 2006; 295:1519-1530.
8. Sanghi. V: Sub Investigator – OASIS 5: Comparison of Fondaparinux and Enoxaparin in acute coronary syndromes. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes. N Engl J Med. 2006 Apr 6; 354(14):1464-76. Epub 2006 Mar 14.
9. Sanghi. V: Sub Investigator – Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes. The MERLIN-TIMI 36 randomized trial. JAMA 2007; 297:1775-1783.
10. Sanghi. V: Sub Investigator – TRITON TIMI 38: Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.
11. Sanghi. V: Sub Investigator: ANTHEM TIMI 32: Giugliano RP, Wiviott SD, Stone PH et al. Recombinant Nematode Anticoagulant Protein c2 in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: The ANTHEM–TIMI-32 Trial J. Am. Coll. Cardiol., Jun 2007; 49: 2398 - 2407.
12. Sanghi. V: Sub Investigator: Giugliano RP, White JA, Bode C, Armstrong PW et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. EARLY ACS investigators. N Engl J Med. 2009 May 21;360(21):2176-90.

1. Sanghi.V : Sub Investigator – PRIMO-CABG II Pexelizumab, a terminal complement inhibitor in coronary artery bypass graft surgery: results from the Pexelizumab for the Reduction of Infarction and Mortality in CABG II trial. American College of Cardiology, 55th Annual Scientific Session; March 11-14, 2006; Atlanta, Georgia.

1. Mention in Americas top cardiologist by Consumer Res Council of America

SCAI Certified In Carotid Angiography and Interventions.
Transthoracic and Transesophageal Echo & Stress Tests.
AICD and Bi-Ventricular AICD Implantations For Advanced Congestive Heart Failure.
Nuclear Cardiology : SPECT Imaging, MUGA Scanning, Perfusion Imaging.